BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update Positive clinical data updates across multiple drug classes...
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 Lead...
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023...
BioNTech veröffentlicht am 6. November 2023 Ergebnisse des dritten Quartals und informiert zur Geschäftsentwicklung und lädt zum „Innovation...
BioNTech Expands Late-Stage Clinical Oncology Portfolio with Initiation of further Phase 2 Trial with mRNA-based Individualized Neoantigen...
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023 Program updates include new data for investigational...
Statement zu Pfizers Abschreibungen im Zusammenhang mit COMIRNATY MAINZ, Deutschland, 16. Oktober 2023 (GLOBE NEWSWIRE) – Am 13. Oktober 2023...
BioNTech und CEPI geben Partnerschaft zur Entwicklung eines mRNA-Mpox-Impfstoffs und zur Unterstützung von CEPIs 100-Tage-Ziel bekannt...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.